Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China.

Background: Hepatitis B virus (HBV) is still one of the serious infectious risks for the blood transfusion safety in China. One plausible reason is the emergence of the variants in the major antigenic alpha determinant within the major hydrophilic region (MHR) of hepatitis B surface antigen (HBsAg), which have been assumed to evade the immune surveillance and pose a challenge to the disease diagnosis. It is well documented that some commercial ELISA kits could detect the wild-type but not the mutant viruses.

[Humoral and cellular immune responses to HBV in the blood donors].

Aim: To study the magnitude and correlation of humoral and cellular immune responses to hepatitis surface antigen(HBsAg), preS1+S2 antigen, and core antigen(HBcAg) in the blood donors.

Methods: Enzyme linked immunosorbent assay (ELISA) was employed to scan the humoral immune responses to HBsAg, preS1+S2 antigen, and HBcAg. Enzyme linked immunospot assay (ELISPOT) was used to check the antigen specific IFN-γ secreting cells stimulated by HBsAg, preS1+S2 antigen or HBcAg in peripheral blood mononuclear cell from blood donors.

[The study of expansion and function HBV special interferon-γ secreting human T lymphocytes in vitro].

Aim: To expand HBV special interferon-γ secreting human T lymphocytes in vitro and sustain the ability to recognize special T cell epitodes of HBcAg.

Methods: After stimulated by peptide 22 hours, feeded with autologous peripheral blood mononuclear cells ( PBMCs) deproliferated by mitomycin C and low concentration of IL-2 to expand in vitro for other 4 weeks. Then cells were collected and tested by flow cells assay every week.